A | BC- free individuals | BC cases | Both | |||||
N (%) | N (%) | N (%) | ||||||
Women with no prescriptions within a year prior to or after the start of follow-up) | 76,413 (82.7) | 14,051(76.7) | 90,464(81.7) | |||||
Women with prescriptions more than a year prior the start of follow-up only | 5199(5.6) | 902(4.9) | 6101(5.5) | |||||
Women with prescriptions only after the start of the follow-up | 8338(9) | 2680(14.6) | 11,018(9.9) | |||||
Women with prescriptions more than 12 months prior and after the start of follow up | 2504(2.7) | 680(3.7) | 3184(2.9) | |||||
92,454 (100) | 18,313 (100) | 110,767 (100) | ||||||
B | Number of antidepressant medication cycles after the start of follow up among those with at least one prescription (N = 14,202) | |||||||
Number of individuals (N, %) | 1 | 2 | 3 | 4 | 5 | 6 | ||
6 645 46.79% | 2 803 19.74% | 1653 11.64% | 1070 7.53% | 752 5.30% | 496 3.50% | |||
7 | 8 | 9 | 10 | 11 | > 11 | |||
310 2.18% | 220 1.55% | 116 0.82% | 79 0.56% | 36 0.25% | 23 0.15% | |||
C | ||||||||
1st | 2nd | 3rd | 4th | 5th | ||||
Median medication cycles duration (years) | 0.25 (3 months) | 0.27 | 0.33 | 0.34 | 0.4 | |||
Median discontinuation period duration(years) | 0.23 | 0.15 | 0.11 | 0.09 | 0.8 |